Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: Analysis of the cooperative cardiovascular project

American Heart Journal

Volumn 139, Issue 6, 2000, Pages 985-992

  Berger, Alan K ^a,c   Radford, Martha J ^a,b   Krumholz, Harlan M ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

^c QUALIDIGM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; AGED; ARTICLE; DISEASE ASSOCIATION; ELDERLY CARE; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYTIC THERAPY; HEART CATHETERIZATION; HEART MUSCLE REPERFUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0034089567     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2000.105703     Document Type: Article

References (29)

1. European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993;329:383-9.
2. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy: the Myocardial Infarction Triage and Intervention Trial. JAMA 1993;270:1211-6.
3. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
4. Rawles JM. Quantification of the benefit of earlier thrombolytic therapy: 5-year results of the Grampian region early anistreplase trial (GREAT). J Am Coll Cardiol 1997;30:1181-6.
5. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996;28:1328-48.
6. GISSI-Avoidable Delay Study Group. Epidemiology of avoidable delay in the care of patients with acute myocardial infarction in Italy: a GISSI-generated study. Arch Intern Med 1995;155:1481-8.
7. Sharkey SW, Brunette DD, Ruiz E, et al. An analysis of time delays preceding thrombolysis for acute myocardial infarction. JAMA 1989;262:3171-4.
8. Turi ZG, Stone PH, Muller JE, et al. Implications for acute intervention related to time of hospital arrival in acute myocardial infarction. Am J Cardiol 1986;58:203-9.
9. Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-5.
10. Newby LK, Rutsch WR, Califf RM, et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. J Am Coll Cardiol 1996;27:1646-55.
11. Gurwitz JH, McLaughlin TJ, Willison DJ, et al. Delayed hospital presentation in patients who have had acute myocardial infarction. Ann Intern Med 1997;126:593-9.
12. Ottesen MM, Kober L, Jorgensen S, et al, on behalf of the Trace Study Group. Determinants of delay between symptoms and hospital admission in 5978 patients with acute myocardial infarction. Eur Heart J 1996;17:429-37.
13. Maynard C, Weaver D, Lambrew C, et al. Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator (data from the National Registry of Myocardial Infarction). Am J Cardiol 1995;76:548-52.
14. Palmer DJ, Cox KL, Dear K, et al. Factors associated with delay in giving thrombolytic therapy after arrival at hospital. Med J Aust 1998;168:111-4.
15. Marciniak TA, Ellerbeck EF, Radford MJ, et al. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA 1998;279:1351-7.
16. Huff ED. Comprehensive reliability assessment and comparison of quality indicators and their components. J Clin Epidemiol 1997;50:1395-1404.
17. American Hospital Association. The annual survey of hospitals. Chicago (III): American Hospital Association; 1994.
18. Fleming C, Fisher ES, Chang CH, et al. Study outcomes and hospital utilization in the elderly: the advantages of a merged data base for Medicare and Veterans Affairs hospitals. Med Care 1992;30:377-91.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
20. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187-92.
21. Normand S-LT, Glickman ME, Sharma RGVRK, et al. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients: results from the Cooperative Cardiovascular Project. JAMA 1996;275:1322-8.
22. Kleinbaum DG. Survival analysis: a self-learning text. New York (NY): Springer-Verlag; 1995.
23. Milavetz JJ, Giebel DW, Christian TF, et al. Time to therapy and salvage in myocardial infarction. J Am Coll Cardiol 1998;31:1246-51.
24. Califf RM, Newby LK. How much do we gain by reducing time to reperfusion therapy? Am J Cardiol 1996;78[suppl 12A]:8-15.
25. Doorey A, Patel S, Reese C, et al. Dangers of delay of initiation of either thrombolysis or primary angioplasty in acute myocardial infarction with increasing use of primary angioplasty. Am J Cardiol 1998;81:1173-7.
26. Markel KN, Marion SA. CQI: improving the time to thrombolytic therapy for patients with acute myocardial infarction in the emergency department. J Emerg Med 1996;14:685-9.
27. Mitchell L, Fife S, Chothia AA, et al. Three teams improving thrombolytic therapy. Jt Comm J Qual Improv 1996;22:379-90.
28. Gilutz H, Battler A, Rabinowitz I, et al. The "door-to-needle blitz" in acute myocardial infarction: the impact of a CQI project. Jt Comm J Qual Improv 1998;24:323-33.
29. Meehan TP, Radford MJ, Vaccarino V, et al. A collaborative project in Connecticut to improve the care of patients with acute myocardial infarction. Jt Comm J Qual Improv 1996;22:751-61.